AI English summary of an SEC filing — figures as filed
Procter & Gamble PGP&G said net sales for the 9 months ended March 31, 2024 rose 3% from a year earlier to $63.5 billion, and net earnings were $11.8 billion (up 4%). Diluted EPS rose 5% to $4.75, and Core EPS rose 15% to $5.19.
Key points
AI summaryP&G said net sales for the 9 months ended March 31, 2024 rose 3% from a year earlier to $63.5 billion, and net earnings were $11.8 billion (up 4%). Diluted EPS rose 5% to $4.75, and Core EPS rose 15% to $5.19.
The company said it recorded a non-cash impairment charge of $1.3 billion before tax ($1.0 billion after tax) on Gillette intangible assets for the 3 months ended December 31, 2023. It attributed the charge to a higher discount rate, the weakening of several currencies against the U.S. dollar, and the impact of the restructuring program.
The company said it announced in December 2023 a restructuring focused on certain Enterprise Markets, including Argentina and Nigeria, and expects to record additional restructuring costs of $1.0 billion to $1.5 billion after tax. It explained that these costs consist mainly of non-cash foreign currency translation losses, which would be recognized when operations in the affected markets are substantially liquidated.
The company said operating cash flow for the 9 months ended March 31, 2024 was $14.1 billion, up $2.6 billion from a year earlier. Adjusted free cash flow was $12.0 billion, and adjusted free cash flow productivity was 93%.
Key figures
Quarter ended March 31, 2024
- Revenue
- $20.2B
- Operating income
- $4.5B
- Net income
- $3.8B
- EPS
- $1.52
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
9-Month Net Sales, Net Earnings and Core EPS
P&G said net sales for the 9 months ended March 31, 2024 rose 3% from a year earlier to $63.5 billion, and net earnings were $11.8 billion (up 4%). Diluted EPS rose 5% to $4.75, and Core EPS rose 15% to $5.19.
Source · Based on the MD&A text of the filing
Gillette Intangible Asset Impairment
The company said it recorded a non-cash impairment charge of $1.3 billion before tax ($1.0 billion after tax) on Gillette intangible assets for the 3 months ended December 31, 2023. It attributed the charge to a higher discount rate, the weakening of several currencies against the U.S. dollar, and the impact of the restructuring program.
Source · Based on the MD&A text of the filing
Limited Market Portfolio Restructuring
The company said it announced in December 2023 a restructuring focused on certain Enterprise Markets, including Argentina and Nigeria, and expects to record additional restructuring costs of $1.0 billion to $1.5 billion after tax. It explained that these costs consist mainly of non-cash foreign currency translation losses, which would be recognized when operations in the affected markets are substantially liquidated.
Source · Based on the MD&A text of the filing
9-Month Operating Cash Flow and Free Cash Flow
The company said operating cash flow for the 9 months ended March 31, 2024 was $14.1 billion, up $2.6 billion from a year earlier. Adjusted free cash flow was $12.0 billion, and adjusted free cash flow productivity was 93%.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…